imiquimod has been researched along with Carcinoma in Situ in 119 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 51 (42.86) | 29.6817 |
| 2010's | 55 (46.22) | 24.3611 |
| 2020's | 13 (10.92) | 2.80 |
| Authors | Studies |
|---|---|
| Bjartling, C; Forslund, O; Kristiansen, S; Svensson, Å; Torbrand, C | 1 |
| Jordanova, ES; van Beurden, M; Voss, FO | 1 |
| Bevilacqua, F; Bleeker, MCG; Bornstein, J; Carcopino, X; Chargari, C; Cruickshank, ME; Erzeneoglu, BE; Esat Temiz, B; Gallio, N; Gultekin, M; Heller, D; Joura, E; Kesic, V; Planchamp, F; Preti, M; Querleu, D; Reich, O; Stockdale, CK; Van Beurden, M; Vieira-Baptista, P; Woelber, L; Zodzika, J | 1 |
| Bevilacqua, F; Bleeker, MCG; Bornstein, J; Carcopino, X; Chargari, C; Cruickshank, ME; Erzeneoglu, BE; Gallio, N; Gultekin, M; Heller, D; Joura, E; Kesic, V; Planchamp, F; Preti, M; Querleu, D; Reich, O; Stockdale, CK; Temiz, BE; Van Beurden, M; Vieira-Baptista, P; Woelber, L; Zodzika, J | 1 |
| Bevilacqua, F; Bornstein, J; Carcopino, X; Chargari, C; Cruickshank, M; Erzeneoglu, E; Esat Temiz, B; Gallio, N; Gultekin, M; Heller, D; Joura, E; Kesic, V; Kyrgiou, M; Madić, T; Planchamp, F; Preti, M; Regauer, S; Reich, O; Stockdale, C; Vieira-Baptista, P; Woelber, L; Zodzika, J | 1 |
| Costa, A; Freitas, G | 1 |
| Assil, S; Burggraaf, J; Buters, TP; Feiss, G; Florencia, E; Klaassen, ES; Moerland, M; Niemeyer-van der Kolk, T; Prens, EP; Rijsbergen, M; Rissmann, R; van Doorn, MBA | 1 |
| Haidopoulos, D; Pergialiotis, V; Rodolakis, A; Rountis, A; Tsetsa, P | 1 |
| Brogden, DRL; Kontovounisios, C; Mills, SC; Pellino, G; Tekkis, P; Walsh, U | 1 |
| Aratake, J; Gou, R; Inayama, Y; Kawamura, A; Kosaka, K; Nakatani, E; Sasagasako, N; Yamada, K; Yamanishi, M; Yamanishi, Y | 1 |
| Aydin, AM; Chahoud, J; Cheryian, SK; Hajiran, A; Pow-Sang, JM; Spiess, PE; Zemp, L | 1 |
| Buckley, K; Chung, CG; Sheldon, JD; Ulman, C | 1 |
| Brewer, JD; Lang, ME; Stewart, JR | 1 |
| Belkoff, LH; Belldegrun, AS; Chamie, K; Donin, NM; Hakim, G; Holden, S; Holldack, J; Karsh, LI; Kivlin, D; Lamm, DL; Lenis, AT; Pantuck, AJ; Pozzi, R; Reddy, M; Shore, N | 1 |
| Baldelli, F; Cavazzoni, E; Leo, CA; Santorelli, C | 1 |
| Bryant, D; Fiander, AN; Hibbitts, S; Hurt, CN; Jones, SEF; Powell, N; Tristram, AJ | 1 |
| Carucci, M; Fiander, A; Hurt, CN; Jones, S; Madden, TA; Naik, R; Nordin, AJ; Powell, N; Tristram, A | 1 |
| Baker, JR; Brand, RM; Cranston, RD; Janocko, L; McGowan, I; Siegel, A | 1 |
| Helm, CW | 1 |
| De Troya-Martín, M; Escudero-Santos, IM; Fernández-Morano, MT; Padilla-España, L; Repiso-Jiménez, JB; Rivas-Ruiz, F; Salas-Márquez, C | 1 |
| de Figueiredo E Silva Rama, AL; de Gois Speck, NM; Nogueira de Carvalho, CR; Ribalta, JCL; Schimidt, MA | 1 |
| Meinert, M; Vorbeck, CS; Østergård, S | 1 |
| Khatun, A; Lotery, H; Sundaram, S | 1 |
| Brinkmann, D; Christie, C; Harvey, G; Hughes, BR; Pontefract, D | 1 |
| Bianchi, L; Caposiena Caro, RD; Di Prete, M; Didona, D; Orlandi, A; Sechi, A | 1 |
| de Vries, HJ; Dijkgraaf, MG; Prins, JM; Richel, O; van Noesel, CJ | 1 |
| Assorgi, C; Biamonti, A; Catalano, A; Cozza, G; Frega, A; Gentile, M; Lombardi, D; Maniglio, P; Marziani, R; Milazzo, GN; Moscarini, M; Ricciardi, E; Scirpa, P; Sesti, F; Sopracordevole, F | 1 |
| Nelson, EL; Stockdale, CK | 1 |
| Bierhoff, E; Dirschka, T; Schmitz, L | 1 |
| Bejarano, PA; Berho, M; Boutros, M | 1 |
| Calzavara Pinton, P; Catricalà, C; Neri, L; Pellacani, G; Peris, K; Peserico, A; Pimpinelli, N | 1 |
| Hanlon, A; Lazova, R; Narayan, D; Sue, GR | 1 |
| Mahner, S; Wölber, L | 1 |
| Dutton, P; Fiander, A; Griffiths, G; Hibbitts, S; Hurt, CN; Jones, S; Madden, T; Man, S; Naik, R; Nordin, AJ; Powell, N; Tristram, A | 1 |
| Biamonti, A; Bianchi, P; Caserta, D; Catalano, A; Cozza, G; Di Martino, G; Frega, A; Gentile, M; Marziani, R; Milazzo, GN; Schimberni, M; Scirpa, P; Sesti, F; Sopracordevole, F; Zinna, M | 1 |
| Chen, FW; Egbert, BM; Kim, DD; Swetter, SM | 1 |
| Galan, A; Higgins, HW; Lee, KC; Leffell, DJ | 1 |
| Bryant, A; Kaushik, S; Lawrie, TA; Nordin, A; Pepas, L | 1 |
| de Witte, CJ; Gerestein, CG; Koeneman, MM; Kruse, AJ; van Beekhuizen, HJ; van de Sande, AJ | 1 |
| Bryant, A; Chakrabarti, M; Kaushik, S; Lawrie, TA; Nordin, A; Pepas, L | 1 |
| Berends-van der Meer, DM; Bosse, T; Daemen, T; Fathers, LM; Fleuren, GJ; Hamming, IL; Hellebrekers, BW; Hollema, H; Kagie, MJ; Kenter, GG; Loof, NM; Löwik, MJ; Melief, CJ; Nijman, HW; Oostendorp, J; Oude Elberink, JH; Schreuder, HW; Stijnen, T; Stynenbosch, LF; Trimbos, JB; Valentijn, AR; van Beurden, M; van der Burg, SH; van Esch, EM; van Poelgeest, MI; Vermeij, R; Welters, MJ | 1 |
| Burdon-Jones, D; Deen, K | 1 |
| Delforge, M; DeWit, S; Feoli, F; Libois, A; Nkuize, M; Willems, N | 1 |
| Jakobsson, M; Kalliala, I; Louvanto, K; Nieminen, P; Paavonen, J; Riska, A; Tainio, K | 1 |
| Cousins, VC; Gamboni, SE; Nixon, RL; Rodrigues, M | 1 |
| Neuhaus, I; North, J; Valdebran, M | 1 |
| Biasoni, D; Catanzaro, MA; Colecchia, M; Giannatempo, P; Necchi, A; Nicolai, N; Paolini, B; Piva, L; Raggi, D; Salvioni, R; Stagni, S; Tesone, A; Torelli, T | 1 |
| Alouini, S; Mathevet, P | 1 |
| Kreuter, A | 1 |
| Daayana, S; Elkord, E; Kitchener, HC; Lear, JT; Stern, PL; Tomlinson, AE; Winters, U | 1 |
| Alessi, E; Arancio, L; Cusini, M; Gaiani, F; Ramoni, S | 1 |
| Baer, KE; Bergman, PJ; Craft, D; Gill, VL; Leung, C | 1 |
| Astner, S; Krueger-Corcoran, D; Roewert-Huber, J; Sterry, W; Stockfleth, E; Ulrich, M | 1 |
| Mahto, M; Nathan, M; O'Mahony, C | 1 |
| Daayana, S; Elkord, E; Kitchener, HC; Pawlita, M; Roden, R; Stern, PL; Winters, U | 1 |
| Kerl, H; Kopera, D | 1 |
| Beckmann, I; Blok, LJ; Heijmans-Antonissen, C; Helmerhorst, TJ; Kleinjan, A; Santegoets, LA; Terlou, A; van Beurden, M; van Seters, M | 2 |
| Liu, XS | 1 |
| Braga, JC; Busam, K; Dusza, SW; Gill, M; Halpern, AC; Marghoob, AA; Scope, A; Terushkin, V | 1 |
| Aaronson, NK; Blok, LJ; Ewing, PC; Gundy, CM; Heijmans-Antonissen, C; Helmerhorst, TJ; Quint, WG; Terlou, A; van Beurden, M; van Seters, M | 1 |
| Kondo, E; Motohashi, T; Okugawa, T; Sagawa, N; Shiozaki, T; Tabata, T; Tanida, K; Toriyabe, K | 1 |
| Bryant, A; Dickinson, HO; Kaushik, S; Nordin, A; Pepas, L | 1 |
| Badger, J; Dadras, SS; Kong, CS; Taube, JM | 1 |
| Alnajjar, HM; Bolgeri, M; Lam, W; Perry, MJ; Rees, RW; Watkin, NA | 1 |
| Cruickshank, ME; Gurumurthy, M | 1 |
| Borrego, J; Figueiredo, A; Paula, T; Ribeiro, F | 1 |
| Brown, J; Frumovitz, M; Milbourne, AM; Munsell, MF; Rhodes, HE; Schmeler, KM; Trimble, CL; Wallbillich, JJ | 1 |
| Clad, A; Fischer, A; Westermann, C | 1 |
| Balaguer, A; Barberà, MJ; Macaya, A; Muñoz-Santos, C | 1 |
| Chang, SD; Chou, HH; Huang, CC; Jao, MS; Jung, SM; Lai, CH; Lin, CT; Qiu, JT; Tang, YH; Wang, CJ; Wu, PJ | 1 |
| Cleaver, L; Knabel, P | 1 |
| Brodersen, JP; Dumke, P; Gutzmer, R; Kapp, A; Kaspari, M; Kiehl, P | 1 |
| Diakomanolis, E; Haidopoulos, D; Stefanidis, K | 1 |
| Guill, CK; Orengo, I; Rosen, T | 1 |
| Fons, G; van Beurden, M; van Seters, M | 1 |
| Krumholz, BA; Travis, LB; Weinberg, JM | 1 |
| Campagne, G; Martínez, A; Roca, M | 1 |
| Dorn, C; Kupka, M; Petrow, W; Richter, ON; Ulrich, U; Wardelmann, E | 1 |
| Barton, S; Berman, B; Hengge, U | 1 |
| Micali, G; Nasca, MR; Tedeschi, A | 1 |
| Danielsen, AG; Sand, C; Weismann, K | 1 |
| Chen, K; Shumack, S | 1 |
| Kossard, S | 1 |
| Arlette, JP; Trotter, MJ | 1 |
| Altmeyer, P; Brockmeyer, NH; Conant, MA; Hochdorfer, B; Kreuter, A; Stücker, M; Weiland, U | 1 |
| Baroni, A; Rossiello, L; Ruocco, E; Ruocco, V | 1 |
| Goorney, BP; Polori, R | 1 |
| Lugones, L; Marchitelli, C; Perrotta, M; Pesce, R; Secco, G; Testa, R | 1 |
| Drijfhout, JW; Heijmans-Antonissen, C; Helmerhorst, TJ; Kenter, GG; Kwappenberg, KM; Melief, CJ; Offringa, R; van Beurden, M; van der Burg, SH; van Poelgeest, MI; van Seters, M | 1 |
| Downs, AM; Geraghty, JM; Jones, C | 1 |
| Fung, MF; Hicks, W; Hopkins, L; Le, T; Menard, C | 1 |
| Derry, S; Hadley, G; Moore, RA | 1 |
| Goh, MS | 1 |
| De Pasquale, R; Micali, G; Nasca, MR | 1 |
| Mings, SM; Ondo, AL; Pestak, RM; Shanler, SD | 1 |
| Altmeyer, P; Brockmeyer, NH; Hochdorfer, B; Kreuter, A; Pfister, H; Stücker, M; Swoboda, J; Weissenborn, SJ; Wieland, U | 1 |
| Bug, R; Gille, J; Kaufmann, R; Kovács, A; Spieth, K; Wolter, M | 1 |
| McQuillan, O; Morgan, E | 1 |
| Bruchim, I; Ferenczy, A; Gotlieb, WH; Grzywacz, K; Mahmud, S; Tunitsky, E | 1 |
| Cerroni, L; Kerl, H; Kodama, K; Wolf, IH | 1 |
| Altmeyer, P; Brockmeyer, NH; Gambichler, T; Kreuter, A; Pfister, H; Potthoff, A; Racz, P; Tenner-Racz, K; Wieland, U | 1 |
| Fung-Kee-Fung, M; Hicks-Boucher, W; Hopkins, L; Le, T; Menard, C; Weberpals, J | 1 |
| Buus, SK; Cramers, M; Mathiesen, O | 1 |
| Correa, LA; He, Q; Herrera, S; Rady, PL; Sanclemente, G; Tyring, SK; Wolff, JC; Zuleta, JJ | 1 |
| Athanasiou, S; Falagas, ME; Iavazzo, C; Pitsouni, E | 1 |
| Altmeyer, P; Brockmeyer, NH; Gambichler, T; Kreuter, A; Pfister, H; Potthoff, A; Stücker, M; Swoboda, J; Wieland, U | 1 |
| de Hullu, JA; Massuger, LF; van de Nieuwenhof, HP; van der Avoort, IA | 1 |
| Aaronson, NK; Beckmann, I; Burger, MP; Eijkemans, MJ; Ewing, PC; Heijmans-Antonissen, C; Helmerhorst, TJ; Kagie, MJ; Kleinjan, A; Meijer, CJ; ten Kate, FJ; van Beurden, M; van Seters, M; Zijlstra, FJ | 1 |
| Weinberg, JM | 1 |
| Cohen, GF; Taliaferro, SJ | 1 |
| Davis, G; Richard, J; Wentworth, J | 1 |
| Pehoushek, J; Smith, KJ | 1 |
| Germain, M; Skelton, H; Smith, KJ | 1 |
| Hengge, UR; Stark, R | 1 |
| Bieber, T; Gerdsen, R; Petrow, W; Richter, O; Uerlich, M | 1 |
| Schroeder, TL; Sengelmann, RD | 1 |
| Jayne, CJ; Kaufman, RH | 1 |
25 review(s) available for imiquimod and Carcinoma in Situ
| Article | Year |
|---|---|
The European Society of Gynaecological Oncology (ESGO), the International Society for the Study of Vulvovaginal Disease (ISSVD), the European College for the Study of Vulval Disease (ECSVD), and the European Federation for Colposcopy (EFC) consensus state
Topics: Carcinoma in Situ; Colposcopy; Female; Humans; Imiquimod; Papillomavirus Infections; Pregnancy; Quality of Life; Retrospective Studies; Uterine Cervical Dysplasia; Uterine Cervical Neoplasms; Vaginal Neoplasms | 2023 |
Non-Excisional therapeutic modalities in vaginal intraepithelial neoplasia.
Topics: Carcinoma in Situ; Female; Humans; Imiquimod; Laser Therapy; Uterine Cervical Dysplasia; Vaginal Neoplasms | 2023 |
Management options for vaginal intraepithelial neoplasia.
Topics: Carcinoma in Situ; Female; Humans; Imiquimod; Neoplasm Recurrence, Local; Retrospective Studies; Vaginal Neoplasms | 2020 |
Evaluating the efficacy of treatment options for anal intraepithelial neoplasia: a systematic review.
Topics: Anus Neoplasms; Carcinoma in Situ; Carcinoma, Squamous Cell; HIV Infections; Humans; Imiquimod; Neoplasm Recurrence, Local; Papillomavirus Infections | 2021 |
Imiquimod for vaginal intraepithelial neoplasia 2-3: A systematic review and meta-analysis.
Topics: Antineoplastic Agents; Carcinoma in Situ; Female; Humans; Imiquimod; Randomized Controlled Trials as Topic; Vaginal Neoplasms | 2021 |
Anogenital syringocystadenocarcinoma papilliferum in situ or anaplastic extramammary Paget disease? A unifying concept and review of the literature.
Topics: Adjuvants, Immunologic; Administration, Topical; Aged; Aged, 80 and over; Carcinoma in Situ; Diagnosis, Differential; Epidermis; Female; Genital Neoplasms, Male; Humans; Imiquimod; Immunohistochemistry; Male; Middle Aged; Paget Disease, Extramammary; Sweat Gland Neoplasms; Treatment Outcome | 2021 |
Efficacy of nonexcisional treatment modalities for superficially invasive and in situ squamous cell carcinoma: A systematic review and meta-analysis.
Topics: Carcinoma in Situ; Carcinoma, Squamous Cell; Fluorouracil; Humans; Imiquimod; Skin Neoplasms | 2022 |
[Vulvar intraepithelial neoplasia].
Topics: Antineoplastic Agents; Carcinoma in Situ; Female; Humans; Imiquimod; Immunocompromised Host; Papillomaviridae; Papillomavirus Infections; Papillomavirus Vaccines; Precancerous Conditions; Vulvar Neoplasms | 2018 |
Anal squamous intraepithelial neoplasia.
Topics: Adjuvants, Immunologic; Administration, Topical; Aminoquinolines; Antimetabolites, Antineoplastic; Anus Neoplasms; Carcinoma in Situ; Carcinoma, Squamous Cell; Fluorouracil; Humans; Imiquimod; Papillomavirus Infections; Papillomavirus Vaccines; Photochemotherapy; Watchful Waiting | 2013 |
Melanoma in situ: Part II. Histopathology, treatment, and clinical management.
Topics: Administration, Topical; Aminoquinolines; Biopsy, Needle; Carcinoma in Situ; Female; Humans; Imiquimod; Immunohistochemistry; Immunotherapy; Injections, Intralesional; Interferon-alpha; Laser Therapy; Male; Melanoma; Melanoma, Cutaneous Malignant; Mohs Surgery; Neoplasm Invasiveness; Neoplasm Staging; Prognosis; Randomized Controlled Trials as Topic; Skin Neoplasms; Treatment Outcome | 2015 |
Medical interventions for high-grade vulval intraepithelial neoplasia.
Topics: Administration, Topical; Adult; Aminoquinolines; Anticarcinogenic Agents; Antineoplastic Agents; Carcinoma in Situ; Cidofovir; Cytosine; Female; Humans; Imiquimod; Indoles; Organophosphonates; Randomized Controlled Trials as Topic; Vulvar Neoplasms | 2015 |
Imiquimod in cervical, vaginal and vulvar intraepithelial neoplasia: a review.
Topics: Aminoquinolines; Antineoplastic Agents; Carcinoma in Situ; Female; Humans; Imiquimod; Papillomavirus Infections; Treatment Outcome; Uterine Cervical Dysplasia; Uterine Cervical Neoplasms; Vaginal Neoplasms; Vulvar Neoplasms | 2015 |
Medical and surgical interventions for the treatment of usual-type vulval intraepithelial neoplasia.
Topics: Adult; Aminoquinolines; Antineoplastic Agents; Carcinoma in Situ; Cidofovir; Cytosine; Disease Progression; Female; Humans; Imiquimod; Indoles; Laser Therapy; Neoplasm Recurrence, Local; Organophosphonates; Photochemotherapy; Prospective Studies; Randomized Controlled Trials as Topic; Retrospective Studies; Treatment Outcome; Vulvar Neoplasms | 2016 |
Imiquimod in the treatment of penile intraepithelial neoplasia: An update.
Topics: Aminoquinolines; Antineoplastic Agents; Carcinoma in Situ; Humans; Imiquimod; Male; Penile Neoplasms | 2017 |
More than a decade on: review of the use of imiquimod in lower anogenital intraepithelial neoplasia.
Topics: Adjuvants, Immunologic; Administration, Topical; Adult; Aged; Aminoquinolines; Antineoplastic Agents; Anus Neoplasms; Carcinoma in Situ; Female; HIV Infections; Humans; Imiquimod; Male; Middle Aged; Penile Neoplasms; Randomized Controlled Trials as Topic; Treatment Outcome; Vulvar Neoplasms | 2010 |
Medical interventions for high grade vulval intraepithelial neoplasia.
Topics: Administration, Topical; Adult; Aminoquinolines; Anticarcinogenic Agents; Antineoplastic Agents; Carcinoma in Situ; Female; Humans; Imiquimod; Indoles; Randomized Controlled Trials as Topic; Vulvar Neoplasms | 2011 |
Differentiated (simplex) vulvar intraepithelial neoplasia: a case report and review of the literature.
Topics: Aged; Aminoquinolines; Antineoplastic Agents; Carcinoma in Situ; Female; Humans; Imiquimod; Lichen Sclerosus et Atrophicus; Precancerous Conditions; Vulvar Neoplasms | 2011 |
Management of vaginal intraepithelial neoplasia.
Topics: Adult; Aged; Aminoquinolines; Antineoplastic Agents; Biological Products; Biopsy, Needle; Brachytherapy; Carcinoma in Situ; Female; Humans; Imiquimod; Immunohistochemistry; Laser Therapy; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Prognosis; Randomized Controlled Trials as Topic; Risk Assessment; Treatment Outcome; Ultrasonic Therapy; Vaginal Neoplasms | 2012 |
Interventions for anal canal intraepithelial neoplasia.
Topics: Aminoquinolines; Anal Canal; Antineoplastic Agents; Anus Neoplasms; Carcinoma in Situ; Humans; Imiquimod; Precancerous Conditions; Randomized Controlled Trials as Topic | 2012 |
Bowenoid papulosis of the vulva-immunotherapeutical approach with topical imiquimod.
Topics: Adjuvants, Immunologic; Administration, Topical; Adult; Aminoquinolines; Bowen's Disease; Carcinoma in Situ; Carcinoma, Squamous Cell; Diabetes Mellitus, Type 1; Female; Humans; Imiquimod; Immunotherapy; Papillomaviridae; Papillomavirus Infections; Vulvar Neoplasms | 2003 |
Successful management of viral infections and other dermatoses with imiquimod 5% cream.
Topics: Adjuvants, Immunologic; Adolescent; Adult; Aged; Aged, 80 and over; Aminoquinolines; Carcinoma in Situ; Child; Condylomata Acuminata; Female; Humans; Imiquimod; Keloid; Male; Middle Aged; Molluscum Contagiosum; Skin Diseases; Virus Diseases; Vulvar Neoplasms | 2003 |
Squamous cell carcinoma in situ of the skin: history, presentation, biology and treatment.
Topics: Aminoquinolines; Antineoplastic Agents; Bowen's Disease; Carcinoma in Situ; Carcinoma, Squamous Cell; Disease Progression; Female; Humans; Imiquimod; Male; Papillomavirus Infections; Skin; Skin Neoplasms; Ultraviolet Rays | 2004 |
Imiquimod for actinic keratosis: systematic review and meta-analysis.
Topics: Aminoquinolines; Antineoplastic Agents; Carcinoma in Situ; Carcinoma, Squamous Cell; Humans; Imiquimod; Keratosis; Ointments; Randomized Controlled Trials as Topic; Skin Neoplasms | 2006 |
Imiquimod for treatment of vulvar and vaginal intraepithelial neoplasia.
Topics: Administration, Cutaneous; Administration, Intravaginal; Aminoquinolines; Antineoplastic Agents; Carcinoma in Situ; Female; Humans; Imiquimod; Precancerous Conditions; Treatment Outcome; Vaginal Neoplasms; Vulvar Neoplasms | 2008 |
Topical therapy for actinic keratoses: current and evolving therapies.
Topics: Administration, Cutaneous; Administration, Topical; Aminoquinolines; Antineoplastic Agents; Carcinoma in Situ; Colchicine; Diclofenac; Fluorouracil; Humans; Imiquimod; Keratosis; Neoplasms, Squamous Cell; Retinoids; Skin Neoplasms; Treatment Outcome; Ultraviolet Rays | 2006 |
19 trial(s) available for imiquimod and Carcinoma in Situ
| Article | Year |
|---|---|
Omiganan Enhances Imiquimod-Induced Inflammatory Responses in Skin of Healthy Volunteers.
Topics: Administration, Cutaneous; Adolescent; Adult; Alphapapillomavirus; Antimicrobial Cationic Peptides; Carcinoma in Situ; Condylomata Acuminata; Drug Synergism; Drug Therapy, Combination; Female; Healthy Volunteers; Humans; Imiquimod; Male; Middle Aged; Proof of Concept Study; Skin; Vulvar Neoplasms; Young Adult | 2020 |
A phase 2 study of TMX-101, intravesical imiquimod, for the treatment of carcinoma in situ bladder cancer.
Topics: Administration, Intravesical; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Carcinoma in Situ; Cytokines; Fatigue; Female; Humans; Imiquimod; Male; Middle Aged; Prospective Studies; Treatment Outcome; Urinary Bladder Neoplasms | 2017 |
Recurrence of vulval intraepithelial neoplasia following treatment with cidofovir or imiquimod: results from a multicentre, randomised, phase II trial (RT3VIN).
Topics: Administration, Topical; Antineoplastic Agents; Carcinoma in Situ; Cidofovir; Female; Humans; Imiquimod; Middle Aged; Neoplasm Recurrence, Local; Prospective Studies; Treatment Outcome; Vulvar Neoplasms | 2018 |
Comparison of imiquimod, topical fluorouracil, and electrocautery for the treatment of anal intraepithelial neoplasia in HIV-positive men who have sex with men: an open-label, randomised controlled trial.
Topics: Aminoquinolines; Anus Neoplasms; Carcinoma in Situ; Electrocoagulation; Fluorouracil; HIV; HIV Infections; HIV Seropositivity; Homosexuality, Male; Humans; Imiquimod; Male; Middle Aged; Netherlands; Papillomaviridae; Prospective Studies | 2013 |
Activity, safety, and feasibility of cidofovir and imiquimod for treatment of vulval intraepithelial neoplasia (RT³VIN): a multicentre, open-label, randomised, phase 2 trial.
Topics: Adult; Aminoquinolines; Antineoplastic Combined Chemotherapy Protocols; Carcinoma in Situ; Cidofovir; Cytosine; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Imiquimod; Middle Aged; Neoplasm Grading; Organophosphonates; Vulvar Neoplasms | 2014 |
Vaccination against Oncoproteins of HPV16 for Noninvasive Vulvar/Vaginal Lesions: Lesion Clearance Is Related to the Strength of the T-Cell Response.
Topics: Adult; Aged; Aminoquinolines; Cancer Vaccines; Carcinoma in Situ; CD8-Positive T-Lymphocytes; Female; Human papillomavirus 16; Humans; Imiquimod; Interferon-gamma; Middle Aged; Oncogene Proteins, Viral; Papillomavirus E7 Proteins; Papillomavirus Infections; Papillomavirus Vaccines; Uterine Cervical Neoplasms; Vaccination; Vaginal Neoplasms; Vulvar Neoplasms; Young Adult | 2016 |
Randomised trial on treatment of vaginal intraepithelial neoplasia-Imiquimod, laser vaporisation and expectant management.
Topics: Administration, Intravaginal; Adult; Aged; Aminoquinolines; Antineoplastic Agents; Carcinoma in Situ; Female; Humans; Imiquimod; Laser Therapy; Middle Aged; Papillomavirus Infections; Pilot Projects; Prospective Studies; Vaginal Neoplasms; Watchful Waiting | 2016 |
Clinical and immunologic results of a phase II trial of sequential imiquimod and photodynamic therapy for vulval intraepithelial neoplasia.
Topics: Administration, Topical; Adult; Aminoquinolines; Antigens, CD; Antineoplastic Agents; Carcinoma in Situ; Combined Modality Therapy; Female; Fluorescent Antibody Technique; Humans; Imiquimod; Immunohistochemistry; Lymphocytes, Tumor-Infiltrating; Middle Aged; Photochemotherapy; T-Lymphocytes, Regulatory; Vulvar Neoplasms | 2008 |
Phase II trial of imiquimod and HPV therapeutic vaccination in patients with vulval intraepithelial neoplasia.
Topics: Adolescent; Adult; Aged; Aminoquinolines; Antigens, Viral; Antineoplastic Combined Chemotherapy Protocols; Cancer Vaccines; Carcinoma in Situ; Drug Tolerance; Female; Human papillomavirus 16; Humans; Imiquimod; Middle Aged; Papillomavirus Vaccines; Vulvar Neoplasms; Young Adult | 2010 |
Treatment of vulvar intraepithelial neoplasia with topical imiquimod: seven years median follow-up of a randomized clinical trial.
Topics: Adult; Aminoquinolines; Antineoplastic Agents; Body Image; Carcinoma in Situ; Carcinoma, Squamous Cell; Disease Progression; Double-Blind Method; Female; Follow-Up Studies; Humans; Imiquimod; Middle Aged; Neoplasm Invasiveness; Quality of Life; Sexuality; Vulvar Neoplasms | 2011 |
Imiquimod in the treatment of multifocal vulvar intraepithelial neoplasia 2/3. Results of a pilot study.
Topics: Administration, Topical; Adult; Aminoquinolines; Antineoplastic Agents; Carcinoma in Situ; Female; Humans; Imiquimod; Middle Aged; Neoplasm Staging; Pilot Projects; Prospective Studies; Time Factors; Vaginal Creams, Foams, and Jellies; Vulvar Neoplasms | 2002 |
Treatment of bowenoid and basaloid vulvar intraepithelial neoplasia 2/3 with imiquimod 5% cream.
Topics: Administration, Topical; Adult; Aminoquinolines; Antineoplastic Agents; Carcinoma in Situ; Female; Humans; Imiquimod; Middle Aged; Papillomavirus Infections; Treatment Outcome; Vulvar Neoplasms | 2004 |
Detection of human papillomavirus (HPV) 16-specific CD4+ T-cell immunity in patients with persistent HPV16-induced vulvar intraepithelial neoplasia in relation to clinical impact of imiquimod treatment.
Topics: Adjuvants, Immunologic; Adult; Aged; Aminoquinolines; Carcinoma in Situ; CD4-Positive T-Lymphocytes; Female; Humans; Imiquimod; Immunity, Cellular; Interferon-gamma; Middle Aged; Papillomaviridae; Treatment Outcome; Vulvar Neoplasms | 2005 |
Fluorouracil does not improve the outcome of imiquimoid treatment of vulval intraepethelial neoplasia.
Topics: Administration, Cutaneous; Aminoquinolines; Antineoplastic Agents; Carcinoma in Situ; Drug Therapy, Combination; Female; Fluorouracil; Humans; Imiquimod; Prospective Studies; Treatment Outcome; Vulvar Neoplasms | 2005 |
Imiquimod treatment of anal intraepithelial neoplasia in HIV-positive men.
Topics: Administration, Cutaneous; Adult; Aged; Aminoquinolines; Antineoplastic Agents; Anus Neoplasms; Carcinoma in Situ; DNA, Viral; HIV Infections; Homosexuality, Male; Humans; Imiquimod; Male; Middle Aged; Papillomaviridae; Papillomavirus Infections; Pilot Projects; Polymerase Chain Reaction; Prospective Studies; Suppositories; Treatment Outcome | 2006 |
Final results of a phase 2 study using continuous 5% Imiquimod cream application in the primary treatment of high-grade vulva intraepithelial neoplasia.
Topics: Administration, Topical; Adult; Aged; Aminoquinolines; Antineoplastic Agents; Carcinoma in Situ; Female; Humans; Imiquimod; Middle Aged; Vulvar Neoplasms | 2007 |
Topical imiquimod can reverse vulvar intraepithelial neoplasia: a randomised, double-blinded study.
Topics: Adjuvants, Immunologic; Administration, Topical; Adult; Aged; Aminoquinolines; Antineoplastic Agents; Carcinoma in Situ; Double-Blind Method; Female; Humans; Imiquimod; Middle Aged; Pain; Prospective Studies; Treatment Outcome; Vulvar Neoplasms | 2007 |
Human papillomavirus (HPV) viral load and HPV type in the clinical outcome of HIV-positive patients treated with imiquimod for anogenital warts and anal intraepithelial neoplasia.
Topics: Adjuvants, Immunologic; Administration, Topical; Adult; AIDS-Related Opportunistic Infections; Aminoquinolines; Anus Diseases; Anus Neoplasms; Carcinoma in Situ; Condylomata Acuminata; Genital Diseases, Male; Humans; Imiquimod; Male; Middle Aged; Papillomaviridae; Papillomavirus Infections; Polymerase Chain Reaction; Treatment Outcome; Viral Load | 2007 |
Treatment of vulvar intraepithelial neoplasia with topical imiquimod.
Topics: Administration, Topical; Adult; Aged; Aminoquinolines; Antineoplastic Agents; Biopsy; Carcinoma in Situ; DNA, Viral; Female; Follow-Up Studies; Humans; Imiquimod; Middle Aged; Papillomaviridae; Papillomavirus Infections; Quality of Life; Vulvar Neoplasms | 2008 |
75 other study(ies) available for imiquimod and Carcinoma in Situ
| Article | Year |
|---|---|
Incidence of penile intraepithelial neoplasia and treatment strategies in Sweden 2000-2019.
Topics: Adult; Carcinoma in Situ; Fluorouracil; Humans; Imiquimod; Incidence; Male; Penile Neoplasms; Sweden; Young Adult | 2022 |
Topical imiquimod as first-line treatment for vulvar intraepithelial neoplasia.
Topics: Administration, Topical; Aminoquinolines; Antineoplastic Agents; Carcinoma in Situ; Female; Humans; Imiquimod; Vulvar Neoplasms | 2022 |
The European Society of Gynaecological Oncology (ESGO), the International Society for the Study of Vulvovaginal Disease (ISSVD), the European College for the Study of Vulval Disease (ECSVD) and the European Federation for Colposcopy (EFC) consensus statem
Topics: Carcinoma in Situ; Cidofovir; Colposcopy; Female; Genital Neoplasms, Female; Humans; Imiquimod; Melanoma; Melanoma, Cutaneous Malignant; Paget Disease, Extramammary; Pregnancy; Skin Neoplasms; Vulvar Neoplasms | 2022 |
The European Society of Gynaecological Oncology (ESGO), the International Society for the Study of Vulvovaginal Disease (ISSVD), the European College for the Study of Vulval Disease (ECSVD) and the European Federation for Colposcopy (EFC) Consensus Statem
Topics: Carcinoma in Situ; Colposcopy; Female; Humans; Imiquimod; Melanoma; Melanoma, Cutaneous Malignant; Paget Disease, Extramammary; Pregnancy; Skin Neoplasms; Squamous Intraepithelial Lesions; Vulvar Neoplasms | 2022 |
Topical chemotherapy for penile carcinoma in situ: Contemporary outcomes and reported toxicity.
Topics: Administration, Topical; Adult; Aged; Antineoplastic Agents; Carcinoma in Situ; Carcinoma, Squamous Cell; Cohort Studies; Fluorouracil; Humans; Imiquimod; Male; Middle Aged; Penile Neoplasms; Treatment Outcome | 2021 |
Response to imiquimod 5% cream as treatment for condyloma and anal intraepithelial neoplasia in HIV-positive and HIV-negative patients.
Topics: Administration, Topical; Adult; Aminoquinolines; Anal Canal; Antineoplastic Agents; Anus Neoplasms; Carcinoma in Situ; Condylomata Acuminata; HIV Infections; Humans; Imiquimod; Italy; Male; Neoplasm Recurrence, Local; Retrospective Studies; Treatment Outcome | 2017 |
Human Papillomavirus DNA Methylation Predicts Response to Treatment Using Cidofovir and Imiquimod in Vulval Intraepithelial Neoplasia 3.
Topics: Aminoquinolines; Biomarkers; Carcinoma in Situ; Cidofovir; Cytosine; DNA Methylation; DNA, Viral; Drug Therapy, Combination; Female; Genes, Viral; Humans; Imiquimod; Neoplasm Staging; Organophosphonates; Papillomaviridae; Papillomavirus Infections; Promoter Regions, Genetic; ROC Curve; Treatment Outcome; Vulvar Neoplasms | 2017 |
A Pilot Study of the Immunologic, Virologic, and Pathologic Consequences of Intra-anal 5% Imiquimod in HIV-1-Infected Men With High-Grade Squamous Intraepithelial Lesions.
Topics: Adult; Aminoquinolines; Anal Canal; Anus Neoplasms; Carcinoma in Situ; Cytokines; HIV Infections; HIV-1; Humans; Imiquimod; Male; Papillomavirus Infections; Pilot Projects; Prospective Studies | 2018 |
Is cidofovir a better treatment than imiquimod for high-grade vulval intraepithelial neoplasia?
Topics: Carcinoma in Situ; Cidofovir; Female; Humans; Imiquimod; Neoplasm Recurrence, Local; Vulvar Neoplasms | 2018 |
Imiquimod anal tampons treatment of anal intraepithelial neoplasia.
Topics: Administration, Rectal; Adult; Antineoplastic Agents; Anus Neoplasms; Carcinoma in Situ; Female; Humans; Imiquimod; Male; Middle Aged; Retrospective Studies; Tampons, Surgical; Treatment Outcome | 2018 |
Imiquimod cream and C02 laser vaporization in vulvar intraepithelial neoplasia (VIN) 2/3 treatment.
Topics: Aminoquinolines; Antineoplastic Agents; Carcinoma in Situ; Female; Humans; Imiquimod; Lasers, Gas; Ointments; Vulvar Neoplasms | 2017 |
Successful treatment of high-grade vulval intra-epithelial neoplasia with imiquimod 5% in a renal transplant recipient.
Topics: Administration, Topical; Antineoplastic Agents; Carcinoma in Situ; Female; Humans; Imiquimod; Immunosuppression Therapy; Kidney; Kidney Transplantation; Middle Aged; Ointments; Papillomaviridae; Papillomavirus Infections; Transplant Recipients; Treatment Outcome; Tumor Virus Infections; Vulva; Vulvar Neoplasms | 2019 |
Impact of smoking on imiquimod response in patients with vulval intraepithelial neoplasia.
Topics: Adjuvants, Immunologic; Administration, Topical; Adult; Aged; Aged, 80 and over; Carcinoma in Situ; Female; Humans; Imiquimod; Middle Aged; Papillomavirus Infections; Retrospective Studies; Smoking; Treatment Outcome; Vulvar Neoplasms | 2019 |
Treatment of recalcitrant squamous carcinoma in situ of penis with tapering imiquimod 5-3.75% cream.
Topics: Carcinoma in Situ; Carcinoma, Squamous Cell; Humans; Imiquimod; Male; Middle Aged; Ointments; Penile Neoplasms | 2019 |
Imiquimod 5% cream versus cold knife excision for treatment of VIN 2/3: a five-year follow-up.
Topics: Adult; Aminoquinolines; Antineoplastic Agents; Carcinoma in Situ; Female; Follow-Up Studies; Humans; Imiquimod; Neoplasm Recurrence, Local; Ointments; Vulvar Neoplasms | 2013 |
Vulvar and vaginal HPV disease.
Topics: Adolescent; Adult; Aged; Aminoquinolines; Antineoplastic Agents; Carcinoma in Situ; Colposcopy; Condylomata Acuminata; Female; Human papillomavirus 11; Human papillomavirus 6; Humans; Imiquimod; Interferon Inducers; Middle Aged; Neoplasm Recurrence, Local; Papillomavirus Infections; Papillomavirus Vaccines; Podophyllotoxin; Pregnancy; Pregnancy Complications, Infectious; Sexually Transmitted Diseases; Trichloroacetic Acid; Vaginal Diseases; Vaginal Neoplasms; Vaginal Smears; Vulvar Diseases; Vulvar Neoplasms; Young Adult | 2013 |
Optical coherence tomography imaging of erythroplasia of Queyrat and treatment with imiquimod 5% cream: a case report.
Topics: Administration, Cutaneous; Aminoquinolines; Antineoplastic Agents; Carcinoma in Situ; Carcinoma, Squamous Cell; Erythroplasia; Humans; Imiquimod; Male; Middle Aged; Penile Neoplasms; Tomography, Optical Coherence | 2014 |
Physicians' opinions and clinical practice patterns for actinic keratosis management in Italy.
Topics: Aminoquinolines; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Attitude of Health Personnel; Carcinoma in Situ; Carcinoma, Squamous Cell; Cryotherapy; Curettage; Dermatology; Dermoscopy; Diclofenac; Disease Management; Guideline Adherence; Humans; Imiquimod; Italy; Keratosis, Actinic; Laser Therapy; Neoplasms, Multiple Primary; Neoplasms, Radiation-Induced; Photochemotherapy; Photosensitivity Disorders; Physicians; Practice Guidelines as Topic; Practice Patterns, Physicians'; Skin Neoplasms; Sunlight; Surveys and Questionnaires | 2014 |
Use of imiquimod for residual acral melanoma.
Topics: Administration, Cutaneous; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Carcinoma in Situ; Female; Follow-Up Studies; Foot Diseases; Humans; Imiquimod; Male; Melanoma; Melanoma, Cutaneous Malignant; Skin Cream; Skin Neoplasms; Treatment Outcome | 2014 |
Surgery or topical therapy for vulval intraepithelial neoplasia.
Topics: Aminoquinolines; Carcinoma in Situ; Cidofovir; Cytosine; Female; Humans; Imiquimod; Organophosphonates; Vulvar Neoplasms | 2014 |
Adjuvant topical treatment with imiquimod 5% after excisional surgery for VIN 2/3.
Topics: Administration, Topical; Aminoquinolines; Antineoplastic Agents; Carcinoma in Situ; Combined Modality Therapy; Female; Humans; Imiquimod; Middle Aged; Neoplasm Recurrence, Local; Prospective Studies; Risk Factors; Vulvar Neoplasms | 2014 |
Imiquimod 5% cream as primary or adjuvant therapy for melanoma in situ, lentigo maligna type.
Topics: Adjuvants, Immunologic; Administration, Topical; Aminoquinolines; Carcinoma in Situ; Chemotherapy, Adjuvant; Cohort Studies; Female; Follow-Up Studies; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Male; Melanoma; Neoplasm Invasiveness; Neoplasm Staging; Retrospective Studies; Risk Assessment; Skin Cream; Skin Neoplasms; Survival Rate; Treatment Outcome | 2015 |
Treatment of anal dysplasia in HIV-positive men who have sex with men in a large AIDS reference centre.
Topics: Adult; Aminoquinolines; Antineoplastic Agents; Anus Neoplasms; Carcinoma in Situ; Feasibility Studies; HIV Infections; Humans; Imiquimod; Male; Middle Aged; Retrospective Studies; Treatment Outcome | 2017 |
Hearing loss in association with topical imiquimod use for squamous cell carcinoma in situ (Bowen disease).
Topics: Aged; Aminoquinolines; Antineoplastic Agents; Bowen's Disease; Carcinoma in Situ; Female; Hearing Loss, Sensorineural; Humans; Imiquimod; Skin Neoplasms | 2016 |
Pseudocarcinomatous Epithelial Hyperplasia Induced by Imiquimod: A Mimic of Cutaneous Squamous Cell Carcinoma.
Topics: Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Biomarkers, Tumor; Carcinoma in Situ; Carcinoma, Squamous Cell; Diagnosis, Differential; Facial Dermatoses; Female; Forehead; Humans; Hyperplasia; Imiquimod | 2017 |
Treatment of Carcinoma In Situ of the Glans Penis With Topical Imiquimod Followed by Carbon Dioxide Laser Excision.
Topics: Administration, Topical; Adult; Aged; Aminoquinolines; Antineoplastic Agents; Carcinoma in Situ; Disease-Free Survival; Humans; Imiquimod; Lasers, Gas; Male; Middle Aged; Papillomavirus Infections; Penile Neoplasms; Survival Analysis; Treatment Outcome | 2017 |
Imiquimod for vulvar intraepithelial neoplasia.
Topics: Aminoquinolines; Antineoplastic Agents; Carcinoma in Situ; Chemotherapy, Adjuvant; Female; Humans; Imiquimod; Papillomavirus Infections; Secondary Prevention; Vulvar Neoplasms | 2008 |
Imiquimod for vulvar intraepithelial neoplasia.
Topics: Aminoquinolines; Antineoplastic Agents; Anus Neoplasms; Carcinoma in Situ; Female; Humans; Imiquimod; Papillomaviridae; Papillomavirus Infections; Viral Load; Vulvar Neoplasms | 2008 |
Penile intraepithelial carcinoma treated with imiquimod 1% in an HIV-positive patient.
Topics: Administration, Topical; Aminoquinolines; Anti-HIV Agents; Carcinoma in Situ; Cell Transformation, Neoplastic; Condylomata Acuminata; Dose-Response Relationship, Drug; Drug Administration Schedule; Follow-Up Studies; HIV Infections; Humans; Imiquimod; Immunohistochemistry; Male; Neoplasm Staging; Penile Diseases; Penile Neoplasms; Risk Assessment; Time Factors; Treatment Outcome | 2009 |
Use of imiquimod 5% cream (Aldara) in cats with multicentric squamous cell carcinoma in situ: 12 cases (2002-2005).
Topics: Aminoquinolines; Animals; Antineoplastic Agents; Bowen's Disease; Carcinoma in Situ; Carcinoma, Squamous Cell; Cat Diseases; Cats; Female; Imiquimod; Kaplan-Meier Estimate; Male; Neoplasm Recurrence, Local; Skin Neoplasms; Treatment Outcome | 2008 |
Reflectance confocal microscopy for noninvasive monitoring of therapy and detection of subclinical actinic keratoses.
Topics: Aged; Aminoquinolines; Antineoplastic Agents; Carcinoma in Situ; Drug Monitoring; Humans; Imiquimod; Keratosis, Actinic; Microscopy, Confocal; Middle Aged; Treatment Outcome | 2010 |
Detection and treatment of preclinical actinic keratoses (PAK).
Topics: Administration, Cutaneous; Aminoquinolines; Antineoplastic Agents; Carcinoma in Situ; Carcinoma, Squamous Cell; Facial Dermatoses; Female; Humans; Imiquimod; Keratosis, Actinic; Middle Aged; Neoplasms, Radiation-Induced; Precancerous Conditions; Skin Aging | 2010 |
Vulvar cancer. Skin changes not to be ignored.
Topics: Administration, Topical; Age Factors; Aged; Aminoquinolines; Antineoplastic Agents; Carcinoma in Situ; Female; Humans; Imiquimod; Laser Therapy; Middle Aged; Precancerous Conditions; Risk Factors; Vulvar Neoplasms | 2010 |
Nonsteroidal anti-inflammatory drugs do not interfere with imiquimod treatment for usual type vulvar intraepithelial neoplasia.
Topics: Aminoquinolines; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Biopsy; Carcinoma in Situ; Cell Separation; Drug Interactions; Female; Flow Cytometry; Fluorescent Dyes; Humans; Imiquimod; Immunohistochemistry; Vulvar Neoplasms | 2011 |
Non-responders to topical imiquimod followed by vaccination therapy in VIN patients may be due to the level of IL10.
Topics: Administration, Topical; Aminoquinolines; Antineoplastic Agents; Carcinoma in Situ; Clinical Trials as Topic; Female; Humans; Imiquimod; Interleukin-10; Vulvar Neoplasms | 2010 |
Agreement on the clinical diagnosis and management of cutaneous squamous neoplasms.
Topics: Algorithms; Aminoquinolines; Biopsy; Carcinoma in Situ; Carcinoma, Squamous Cell; Cryosurgery; Curettage; Dermatology; Diagnosis, Differential; Fluorouracil; Humans; Imiquimod; Keratosis, Actinic; Mohs Surgery; Photochemotherapy; Precancerous Conditions; Reproducibility of Results; Skin Neoplasms; Terminology as Topic; United States | 2010 |
A case of usual (basaloid)-type vulvar intraepithelial neoplasia that failed to respond to imiquimod cream: clinical implications.
Topics: Aminoquinolines; Antineoplastic Agents; Carcinoma in Situ; Drug Resistance, Neoplasm; Female; Humans; Imiquimod; Middle Aged; Neoplasm Staging; Treatment Failure; Vulvar Neoplasms | 2011 |
Imiquimod-induced clearance of HPV is associated with normalization of immune cell counts in usual type vulvar intraepithelial neoplasia.
Topics: Adult; Aminoquinolines; Antineoplastic Agents; Biomarkers, Tumor; Carcinoma in Situ; Case-Control Studies; Cyclin-Dependent Kinase Inhibitor p16; DNA, Viral; Female; Humans; Imiquimod; Immunoenzyme Techniques; Lymphocyte Count; Middle Aged; Papillomaviridae; Papillomavirus Infections; Polymerase Chain Reaction; Prognosis; Vulvar Neoplasms; Young Adult | 2010 |
Treatment of carcinoma in situ of the glans penis with topical chemotherapy agents.
Topics: Administration, Cutaneous; Aged; Aminoquinolines; Antineoplastic Agents; Carcinoma in Situ; Fluorouracil; Humans; Imiquimod; Male; Middle Aged; Penile Neoplasms; Retrospective Studies; Time Factors; Treatment Outcome | 2012 |
Vulvar intraepithelial neoplasia: evaluation of treatment modalities.
Topics: Administration, Topical; Adult; Aged; Aminoquinolines; Biopsy, Needle; Carcinoma in Situ; Cohort Studies; Female; Follow-Up Studies; Gynecologic Surgical Procedures; Humans; Imiquimod; Immunohistochemistry; Laser Therapy; Lasers, Gas; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Portugal; Retrospective Studies; Risk Assessment; Treatment Outcome; Vulvar Neoplasms; Young Adult | 2012 |
Vulvar intraepithelial neoplasia (VIN 2/3): comparing clinical outcomes and evaluating risk factors for recurrence.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Carcinoma in Situ; Combined Modality Therapy; Female; Humans; Imiquimod; Laser Therapy; Middle Aged; Multivariate Analysis; Neoplasm Recurrence, Local; Neoplasm Staging; Proportional Hazards Models; Retrospective Studies; Risk Factors; Treatment Outcome; Vulva; Vulvar Neoplasms; Young Adult | 2012 |
Treatment of vulvar intraepithelial neoplasia with topical 5% imiquimod cream.
Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Carcinoma in Situ; Female; Follow-Up Studies; Human papillomavirus 16; Humans; Imiquimod; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Papillomavirus Infections; Remission Induction; Retrospective Studies; Treatment Outcome; Vaginal Creams, Foams, and Jellies; Vulvar Neoplasms | 2013 |
Topical imiquimod treatment for human papillomavirus infection in patients with and without cervical/vaginal intraepithelial neoplasia.
Topics: Adjuvants, Immunologic; Administration, Topical; Adult; Aged; Aged, 80 and over; Aminoquinolines; Carcinoma in Situ; DNA, Viral; Female; Humans; Imiquimod; Middle Aged; Papillomaviridae; Papillomavirus Infections; Retrospective Studies; Uterine Cervical Neoplasms; Vaginal Neoplasms | 2012 |
Arbor cutis: hyperkeratotic plaque secondary to the use of imiquimod for the treatment of squamous cell carcinoma in situ.
Topics: Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Carcinoma in Situ; Carcinoma, Squamous Cell; Combined Modality Therapy; Drug Eruptions; Female; Forearm; Humans; Imiquimod; Keratosis; Skin Neoplasms | 2013 |
Imiquimod 5% cream in the treatment of human papillomavirus-16-positive erythroplasia of Queyrat.
Topics: Adjuvants, Immunologic; Administration, Topical; Adult; Aminoquinolines; Antineoplastic Agents; Carcinoma in Situ; Erythroplasia; Humans; Imiquimod; Male; Papillomaviridae; Papillomavirus Infections; Penile Neoplasms; Penis; Tumor Virus Infections | 2002 |
Treatment of high-grade vaginal intraepithelial neoplasia with imiquimod cream.
Topics: Adjuvants, Immunologic; Administration, Intravaginal; Adult; Aminoquinolines; Antineoplastic Agents; Carcinoma in Situ; Female; Humans; Imiquimod; Middle Aged; Neoplasm Staging; Tumor Suppressor Protein p53; Vaginal Creams, Foams, and Jellies; Vaginal Neoplasms | 2002 |
Treatment of squamous cell carcinoma in situ of the penis with 5% imiquimod cream: a case report.
Topics: Adjuvants, Immunologic; Administration, Topical; Adult; Aminoquinolines; Carcinoma in Situ; Carcinoma, Squamous Cell; Humans; Imiquimod; Interferon Inducers; Male; Penile Neoplasms | 2002 |
Successful treatment of vulvar intraepithelial neoplasia with topical imiquimod 5% cream in a lung transplanted patient.
Topics: Administration, Topical; Adult; Aminoquinolines; Antineoplastic Agents; Carcinoma in Situ; Female; Humans; Imiquimod; Papillomaviridae; Papillomavirus Infections; Treatment Outcome; Tumor Virus Infections; Vulvar Neoplasms | 2002 |
Successful treatment of a high-grade intraepithelial neoplasia with imiquimod, with vulvar pemphigus as a side effect.
Topics: Adjuvants, Immunologic; Adult; Aminoquinolines; Antineoplastic Agents; Carcinoma in Situ; Carcinoma, Squamous Cell; Female; Genital Neoplasms, Female; Humans; Imiquimod; Papillomaviridae; Papillomavirus Infections; Pemphigus; Treatment Outcome; Uterine Cervical Neoplasms; Vaginal Neoplasms; Vulvar Diseases; Vulvar Neoplasms | 2003 |
Topical treatment of intraepithelial penile carcinoma with imiquimod.
Topics: Administration, Topical; Aged; Aminoquinolines; Antineoplastic Agents; Carcinoma in Situ; Erythema; Humans; Imiquimod; Male; Middle Aged; Pain; Penile Neoplasms; Treatment Outcome | 2003 |
Treatment of Bowen's disease of the penis with imiquimod 5% cream.
Topics: Administration, Topical; Aminoquinolines; Antineoplastic Agents; Bowen's Disease; Carcinoma in Situ; Carcinoma, Squamous Cell; Emollients; Humans; Imiquimod; Male; Middle Aged; Ointments; Penile Neoplasms; Treatment Outcome | 2003 |
Treatment of Bowen's disease using a cycle regimen of imiquimod 5% cream.
Topics: Adjuvants, Immunologic; Administration, Topical; Aged; Aged, 80 and over; Aminoquinolines; Bowen's Disease; Carcinoma in Situ; Carcinoma, Squamous Cell; Drug Administration Schedule; Female; Humans; Imiquimod; Middle Aged; Ointments; Skin Neoplasms; Treatment Outcome | 2003 |
Treatment of large facial Bowen's disease: case report.
Topics: Administration, Topical; Aged; Aminoquinolines; Antineoplastic Agents; Bowen's Disease; Carcinoma in Situ; Carcinoma, Squamous Cell; Facial Neoplasms; Female; Humans; Imiquimod; Ointments; Treatment Outcome | 2003 |
Treatment of anal intraepithelial neoplasia in patients with acquired HIV with imiquimod 5% cream.
Topics: Adjuvants, Immunologic; Aminoquinolines; Antineoplastic Agents; Anus Neoplasms; Carcinoma in Situ; HIV Infections; Humans; Imiquimod; Male; Ointments | 2004 |
Imiquimod contact pemphigus: a comment.
Topics: Administration, Topical; Adrenal Cortex Hormones; Adult; Aminoquinolines; Antineoplastic Agents; Carcinoma in Situ; Clobetasol; Contraceptives, Oral; Female; Humans; Imiquimod; Papillomavirus Infections; Pemphigus; Treatment Outcome; Vulvar Diseases; Vulvar Neoplasms | 2004 |
A case of Bowenoid papulosis of the penis successfully treated with topical imiquimod cream 5%.
Topics: Administration, Topical; Adult; Aminoquinolines; Antineoplastic Agents; Bowen's Disease; Carcinoma in Situ; Humans; Imiquimod; Immunocompetence; Male; Penile Neoplasms; Penis; Treatment Outcome | 2004 |
Preliminary results of 5% imiquimod cream in the primary treatment of vulva intraepithelial neoplasia grade 2/3.
Topics: Adjuvants, Immunologic; Adult; Aged; Aminoquinolines; Carcinoma in Situ; Colposcopy; Female; Humans; Imiquimod; Middle Aged; Prospective Studies; Remission Induction; Vulvar Neoplasms | 2006 |
Invasive squamous cell carcinoma after treatment of carcinoma in situ with 5% imiquimod cream.
Topics: Administration, Topical; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Carcinoma in Situ; Carcinoma, Squamous Cell; Disease Progression; Head and Neck Neoplasms; Humans; Imiquimod; Leg; Lymph Node Excision; Lymphatic Metastasis; Male; Middle Aged; Neoplasms, Second Primary; Scalp; Skin Neoplasms; Treatment Outcome | 2006 |
Erythroplasia of Queyrat treated with imiquimod 5% cream.
Topics: Adjuvants, Immunologic; Aminoquinolines; Carcinoma in Situ; Drug Administration Schedule; Erythroplasia; Humans; Imiquimod; Male; Middle Aged; Ointments; Penile Neoplasms; Treatment Outcome | 2006 |
Topical combination therapy for cutaneous squamous cell carcinoma in situ with 5-fluorouracil cream and imiquimod cream in patients who have failed topical monotherapy.
Topics: Administration, Cutaneous; Aged; Aminoquinolines; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma in Situ; Carcinoma, Squamous Cell; Cytokines; Drug Evaluation; Drug Synergism; Fingers; Fluorouracil; Humans; Imiquimod; Male; Middle Aged; Ointments; Prodrugs; Remission Induction; Skin Neoplasms; Toll-Like Receptor 7; Toll-Like Receptor 8 | 2006 |
Topical imiquimod: effectiveness in intraepithelial melanoma of oral mucosa.
Topics: Administration, Topical; Aged; Aminoquinolines; Antineoplastic Agents; Carcinoma in Situ; Female; Humans; Imiquimod; Melanoma; Mouth Mucosa; Mouth Neoplasms; Skin Neoplasms | 2006 |
Treatment of vulvar intraepithelial neoplasia using topical imiquimod 5% cream in a genitourinary medicine clinic setting.
Topics: Administration, Topical; Adult; Ambulatory Care Facilities; Aminoquinolines; Antineoplastic Agents; Carcinoma in Situ; Female; Humans; Imiquimod; Vulvar Neoplasms | 2007 |
HPV-related vulvar intraepithelial neoplasia: outcome of different management modalities.
Topics: Adjuvants, Immunologic; Adult; Aged; Aminoquinolines; Carcinoma in Situ; Catheter Ablation; Female; Follow-Up Studies; Humans; Imiquimod; Laser Therapy; Middle Aged; Papillomavirus Infections; Precancerous Conditions; Retrospective Studies; Treatment Outcome; Vulvar Neoplasms | 2007 |
Nature of inflammatory infiltrate in superficial cutaneous malignancies during topical imiquimod treatment.
Topics: Adjuvants, Immunologic; Aged; Aged, 80 and over; Aminoquinolines; Biomarkers, Tumor; Bowen's Disease; Carcinoma in Situ; Carcinoma, Basal Cell; Female; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Inflammation; Keratosis; Male; Melanoma; Middle Aged; Skin Neoplasms | 2007 |
p16ink4a expression decreases during imiquimod treatment of anal intraepithelial neoplasia in human immunodeficiency virus-infected men and correlates with the decline of lesional high-risk human papillomavirus DNA load.
Topics: Administration, Cutaneous; Adult; AIDS-Related Opportunistic Infections; Aminoquinolines; Antineoplastic Agents; Anus Neoplasms; Biomarkers, Tumor; Carcinoma in Situ; Cyclin-Dependent Kinase Inhibitor p16; DNA, Viral; Homosexuality, Male; Humans; Imiquimod; Ki-67 Antigen; Male; Papillomaviridae; Papillomavirus Infections; Pilot Projects; Precancerous Conditions; Viral Load | 2007 |
Imiquimod leads to a decrease of human papillomavirus DNA and to a sustained clearance of anal intraepithelial neoplasia in HIV-infected men.
Topics: Aminoquinolines; Antineoplastic Agents; Anus Neoplasms; Carcinoma in Situ; DNA, Viral; Follow-Up Studies; HIV Infections; Human papillomavirus 16; Human papillomavirus 18; Humans; Imiquimod; Longitudinal Studies; Male; Papillomaviridae; Prospective Studies; Treatment Outcome | 2008 |
Letter to the Editor concerning "Topical imiquimod can reverse vulvar intraepithelial neoplasia: a randomized, double blinded study." Gynecologic Oncology 107 (2007) 219-222.
Topics: Administration, Topical; Aminoquinolines; Antineoplastic Agents; Carcinoma in Situ; Double-Blind Method; Female; Humans; Imiquimod; Randomized Controlled Trials as Topic; Vulvar Neoplasms | 2008 |
Bowen's disease of the penis treated with topical imiquimod 5% cream.
Topics: Adjuvants, Immunologic; Administration, Topical; Adult; Aminoquinolines; Bowen's Disease; Carcinoma in Situ; Carcinoma, Squamous Cell; Humans; Imiquimod; Male; Ointments; Penile Neoplasms; Skin Neoplasms | 2008 |
Self-administered topical imiquimod treatment of vulvar intraepithelial neoplasia. A report of four cases.
Topics: Adjuvants, Immunologic; Administration, Cutaneous; Adult; Aminoquinolines; Carcinoma in Situ; Condylomata Acuminata; Drug Administration Schedule; Female; Humans; Imiquimod; Middle Aged; Neoplasm Recurrence, Local; Ointments; Papillomaviridae; Self Administration; Tumor Virus Infections; Vulvar Neoplasms | 2000 |
Imiquimod and 5% fluorouracil therapy for anal and perianal squamous cell carcinoma in situ in an HIV-1-positive man.
Topics: Aminoquinolines; Antineoplastic Combined Chemotherapy Protocols; Anus Neoplasms; Carcinoma in Situ; Carcinoma, Squamous Cell; Drug Administration Schedule; Fluorouracil; HIV Infections; HIV-1; Humans; Imiquimod; Male; Middle Aged | 2001 |
Bowen's disease (squamous cell carcinoma in situ) in immunosuppressed patients treated with imiquimod 5% cream and a cox inhibitor, sulindac: potential applications for this combination of immunotherapy.
Topics: Adjuvants, Immunologic; Administration, Topical; Aged; Aminoquinolines; Antineoplastic Agents; Bowen's Disease; Carcinoma in Situ; Cyclooxygenase Inhibitors; Drug Therapy, Combination; Female; Humans; Imiquimod; Immunosuppression Therapy; Immunotherapy; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Neoplasms, Second Primary; Ointments; Skin Neoplasms; Sulindac | 2001 |
Topical imiquimod to treat intraepidermal carcinoma.
Topics: Administration, Cutaneous; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Carcinoma in Situ; Carcinoma, Squamous Cell; Female; Humans; Imiquimod; Keratosis; Male; Middle Aged; Nose; Photosensitivity Disorders; Precancerous Conditions; Skin Neoplasms; Thorax | 2001 |
Successful topical immunotherapy of bowenoid papulosis with imiquimod.
Topics: Adult; Aminoquinolines; Antineoplastic Agents; Carcinoma in Situ; Carcinoma, Squamous Cell; Female; Humans; Imiquimod; Interferon Inducers; Vulvar Neoplasms | 2001 |
Squamous cell carcinoma in situ of the penis successfully treated with imiquimod 5% cream.
Topics: Administration, Topical; Aged; Aminoquinolines; Antineoplastic Agents; Bowen's Disease; Carcinoma in Situ; Carcinoma, Squamous Cell; Humans; Imiquimod; Male; Ointments; Penile Neoplasms; Skin Neoplasms | 2002 |
Treatment of vulvar intraepithelial neoplasia 2/3 with imiquimod.
Topics: Administration, Cutaneous; Adult; Aged; Aminoquinolines; Antineoplastic Agents; Carcinoma in Situ; Disease-Free Survival; Female; Humans; Imiquimod; Medical Records; Middle Aged; Neoplasm Recurrence, Local; Retrospective Studies; Texas; Treatment Outcome; Vulvar Neoplasms | 2002 |